Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Last trade$281.21
Day change-$2.64 (-0.93%)
Day range$278.46 – $284.64
Volume769,625
Market cap$65.61B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$65.61B
Price / earnings
36.09×
Price / book
-21.69×
Price / sales
0.25×
EV / sales
0.27×
EV / EBITDA
17.77×
Profitability
Earnings per share
$7.87
Return on assets
3.05%
Return on equity
-60.1%
Dividend yield
0.74%
Liquidity and leverage
Debt / equity
-2.91×
Current ratio
0.88×
Quick ratio
0.49×
Cash ratio
0.11×
Cash flow
Price / cash flow
11.72×
Price / free cash flow
13.39×
Free cash flow
$4.9B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for CAH, quarterly periods
Line item
Q1 FY2027 Sep 30, 2026
Q4 FY2026 Jun 30, 2026
Q3 FY2026 Mar 31, 2026
Q2 FY2026 Dec 31, 2025
Q1 FY2026 Sep 30, 2025
Q4 FY2025 Jun 30, 2025
Q3 FY2025 Mar 31, 2025
Q2 FY2025 Dec 31, 2024
Revenue
$67.51B
$63.67B
$60.94B
$65.63B
$64.01B
$60.16B
$54.88B
$55.26B
Cost of revenue
$64.92B
$61.11B
$58.44B
$63.23B
$61.69B
$57.96B
$52.76B
$53.32B
Gross profit
$2.6B
$2.56B
$2.5B
$2.4B
$2.32B
$2.2B
$2.12B
$1.94B
Selling, general and administrative
$1.6B
$1.63B
$1.54B
$1.5B
$1.46B
$1.48B
$1.32B
$1.31B
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$1.85B
$1.83B
$1.8B
$1.69B
$1.65B
$1.74B
$1.41B
$1.39B
Operating income
$749M
$733M
$694M
$707M
$670M
$461M
$713M
$549M
Interest expense
-$73M
-$79M
-$101M
-$88M
-$80M
-$74M
-$74M
-$35M
Income before taxes
$688M
$554M
$392M
$630M
$598M
$384M
$665M
$511M
Income taxes
$132M
$154M
$12M
$159M
$144M
$141M
$157M
$110M
Net income
$556M
$400M
$380M
$471M
$454M
$243M
$508M
$401M
Net income attributable to common shareholders
$554M
$398M
$399M
$467M
$450M
$239M
$506M
$400M
EBITDA
$972M
$1.01B
$978M
$930M
$923M
$688M
$843M
$722M
Basic earnings per share
$2.39
$1.69
$1.69
$1.98
$1.89
$1.00
$2.11
$1.65
Diluted earnings per share
$2.38
$1.69
$1.69
$1.97
$1.88
$1.00
$2.10
$1.65
Recent news
Company coverage with links to the original publishers.
Following NVIDIA CEO Jensen Huang's resignation that pressured tech stocks, Zacks recommends five dividend growth stocks as a steadier investment strategy amid market volatility and regulatory uncertainty. The selected companies—J.M. Smucker, Taiwan Semiconductor, Corning, Lockheed Martin, and Cardinal Health—offer consistent dividend growth, solid fundamentals, and downside protection in uncertain times.
Following NVIDIA CEO Jensen Huang's resignation that rattled tech stocks, investors are turning to dividend growth stocks for stability. Five stocks—J.M. Smucker, Taiwan Semiconductor, Corning, Lockheed Martin, and Cardinal Health—are highlighted as solid choices offering consistent dividend growth, reliable cash flow, and downside protection amid market volatility and regulatory uncertainty.
Zacks Premium offers investment tools including the Zacks Rank and Style Scores to help investors identify high-performing stocks. The Style Scores rate stocks on value, growth, and momentum characteristics, with the VGM Score combining all three. Cardinal Health (CAH) is highlighted as a #2 Buy with an A VGM Score and strong growth prospects, forecasting 14.7% year-over-year earnings growth.
Cardinal Health (CAH) is highlighted as a momentum investment pick with a Zacks Rank #2 (Buy) and Momentum Style Score of B. The stock has outperformed its industry with 8.48% weekly gains and 35.15% annual returns, while recent earnings estimate revisions have moved higher, supporting its bullish outlook.
Zacks highlights four stocks with strong interest coverage ratios, indicating solid ability to meet debt obligations: Stride (LRN) with Zacks Rank #1, Ralph Lauren (RL) with 8% sales growth expected, Cardinal Health (CAH) with 13.9% EPS growth forecast, and Vertiv Holdings (VRT) with exceptional 69.5% EPS growth projected.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.5158 per share
Declared
Nov 11, 2026
Ex-dividend
Jan 4, 2027
Pay date
Jan 15, 2027
Ex-dividend
Amount / share
Pay date
Type
Oct 1, 2026
$0.5158
Oct 15, 2026
recurring
Jul 1, 2026
$0.5158
Jul 15, 2026
recurring
Apr 1, 2026
$0.5107
Apr 15, 2026
recurring
Jan 2, 2026
$0.5107
Jan 15, 2026
recurring
Oct 1, 2025
$0.5107
Oct 15, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.